Overview
Location
United States, Massachusetts, Lexington
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 9, 2024 | CSA Medical Raises $53M in Series D Financing | RejuvenAir Metered Cryospray CSA Medical, a Boston, Ma-based developer of The RejuvenAir® System, a medical device advancing liquid nitrogen spray cryotherapy for the treatment of chronic bronchitis, raised $53M in Series D funding. The rou... |
| RejuvenAir | “RejuvenAir System aims to treat Chronic Bronchitis. The SPRAY-CB trial is evaluating the safety of the device and is currently recruiting in the USA.” |
Reviews 0
FAQ about CSA Medical
What has the press written about CSA Medical?
Parsers VC has collected 3 articles mentioning CSA Medical, among them “CSA Medical Raises $53M in Series D Financing” (Sep 9, 2024) and “RejuvenAir”.
Is CSA Medical still active?
CSA Medical is probably closed: its latest activity on Parsers VC dates from Sep 10, 2024.